Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Filgrastim for Premature Ovarian Insufficiency
NCT02783937Phase 4Completed
- Sponsor
- South Valley University
- Start
- Nov 2016
- Primary completion
- Dec 2020
- Modality
- Cytokines & Interferons
01
Overview
Phase 4, randomised, double-blind trial of filgrastim in premature ovarian insufficiency (POI) (2 arms), sponsored by South Valley University. Primary endpoint: Return of menses at 6 months. Started Nov 2016; status: completed.
02
Drugs
filgrastim
03
Conditions
premature ovarian insufficiency (POI)
Beyond the preview
Go deeper on NCT02783937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02783937.